Edition:
United Kingdom

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

2.83USD
7 Dec 2018
Change (% chg)

$0.04 (+1.43%)
Prev Close
$2.79
Open
$2.90
Day's High
$2.94
Day's Low
$2.82
Volume
81,821
Avg. Vol
135,286
52-wk High
$5.10
52-wk Low
$2.20

Select another date:

Fri, Dec 7 2018

Novartis to launch Adamis' EpiPen rival in U.S. next year

Dec 6 Novartis AG said its U.S. unit Sandoz Inc will launch Adamis Pharmaceuticals Corp's emergency allergy shots next year in the United States, at a price that is about 16 percent below that of similar rival products.

BRIEF-Adamis Pharmaceuticals Provides Update On Symjepi's U.S. Launch

* ADAMIS PHARMACEUTICALS PROVIDES UPDATE ON THE U.S. LAUNCH OF SYMJEPI

BRIEF-Adamis Pharmaceuticals Says Working With Sandoz To Prepare Symjepi Launch

* ADAMIS PHARMACEUTICALS - WORKING CLOSELY WITH SANDOZ TO PREPARE A SUCCESSFUL LAUNCH FOR SYMJEPI

Select another date: